<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Interactive Investment Thesis: AbCellera (ABCL)</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.2/dist/chart.umd.min.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Poppins:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    
    <!-- Chosen Palette: Serene Tech -->
    <!-- Application Structure Plan: A single-page application with a fixed top navigation bar and tabbed content sections. This dashboard-like structure (Thesis Summary, The Platform, Business & Pipeline, Market Dynamics, Financials & Risks) allows users to explore the dense investment thesis in thematic, digestible chunks. The non-linear navigation empowers users to jump to sections of interest, prioritizing usability and exploration over a static, linear document format. This design choice makes the complex information more accessible and engaging. -->
    <!-- Visualization & Content Choices: The application translates text and tables into interactive visualizations. Key data like financials and partner growth are shown in Chart.js bar/line charts for clear trend analysis. Proportional data like analyst ratings are shown in a donut chart. The platform's capabilities and risks are presented in interactive card/accordion formats to avoid walls of text. An interactive timeline visualizes company milestones. This approach was chosen to make data-heavy sections more intuitive and to encourage user interaction, transforming passive reading into active exploration, all while adhering to the NO SVG/Mermaid constraint. -->
    <!-- CONFIRMATION: NO SVG graphics used. NO Mermaid JS used. -->

    <style>
        body {
            font-family: 'Poppins', sans-serif;
            background-color: #f8fafc; /* slate-50 */
            color: #1e293b; /* slate-800 */
        }
        .nav-link {
            transition: all 0.3s ease;
            cursor: pointer;
            border-bottom: 2px solid transparent;
        }
        .nav-link.active, .nav-link:hover {
            color: #334155; /* slate-700 */
            border-bottom-color: #4f46e5; /* indigo-600 */
        }
        .content-section {
            display: none;
        }
        .content-section.active {
            display: block;
        }
        .stat-card {
            background-color: white;
            border-radius: 0.75rem;
            padding: 1.5rem;
            box-shadow: 0 4px 6px -1px rgb(0 0 0 / 0.1), 0 2px 4px -2px rgb(0 0 0 / 0.1);
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }
        .stat-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 10px 15px -3px rgb(0 0 0 / 0.1), 0 4px 6px -4px rgb(0 0 0 / 0.1);
        }
        .chart-container {
            position: relative;
            margin: auto;
            height: 350px;
            width: 100%;
            max-width: 800px;
            max-height: 400px;
        }
        @media (min-width: 768px) {
            .chart-container {
                height: 400px;
            }
        }
        .kpi-value {
            color: #4f46e5;
        }
        .kpi-label {
            color: #64748b;
        }
        .section-title {
            color: #1e293b; /* slate-800 */
        }
        .section-intro {
            color: #475569; /* slate-600 */
            max-width: 48rem;
            margin-left: auto;
            margin-right: auto;
        }
        .accordion-item button {
            transition: background-color 0.3s ease;
        }
        .accordion-item .accordion-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease-in-out;
        }
        .timeline::before {
            content: '';
            position: absolute;
            left: 50%;
            transform: translateX(-50%);
            top: 0;
            bottom: 0;
            width: 2px;
            background-color: #e2e8f0; /* slate-200 */
        }
        .timeline-item {
            position: relative;
        }
        .timeline-content {
            transition: all 0.3s ease;
        }
        .timeline-item:hover .timeline-content {
            transform: scale(1.02);
            box-shadow: 0 10px 15px -3px rgb(0 0 0 / 0.1), 0 4px 6px -4px rgb(0 0 0 / 0.1);
        }
        .timeline-dot {
            position: absolute;
            left: 50%;
            top: 50%;
            transform: translate(-50%, -50%);
            width: 1rem;
            height: 1rem;
            border-radius: 9999px;
            background-color: white;
            border: 2px solid #4f46e5;
            z-index: 10;
        }
    </style>
</head>
<body class="antialiased">

    <header class="bg-white/80 backdrop-blur-sm sticky top-0 z-50 shadow-sm">
        <nav class="container mx-auto px-4 sm:px-6 lg:px-8">
            <div class="flex items-center justify-between h-16">
                <div class="flex items-center space-x-4">
                    <a href="index.html" class="text-slate-600 hover:text-slate-800 text-sm font-medium">
                        ‚Üê Back to Research Hub
                    </a>
                    <h1 class="text-xl font-bold text-slate-800">AbCellera (ABCL) Thesis</h1>
                </div>
                <div class="hidden md:block">
                    <div class="ml-10 flex items-baseline space-x-4">
                        <a onclick="showSection('summary')" class="nav-link px-3 py-2 text-sm font-medium text-slate-500 active">Thesis Summary</a>
                        <a onclick="showSection('platform')" class="nav-link px-3 py-2 text-sm font-medium text-slate-500">The Platform</a>
                        <a onclick="showSection('pipeline')" class="nav-link px-3 py-2 text-sm font-medium text-slate-500">Business & Pipeline</a>
                        <a onclick="showSection('market')" class="nav-link px-3 py-2 text-sm font-medium text-slate-500">Market Dynamics</a>
                        <a onclick="showSection('financials')" class="nav-link px-3 py-2 text-sm font-medium text-slate-500">Financials & Risks</a>
                    </div>
                </div>
                <div class="md:hidden">
                    <select onchange="showSection(this.value)" class="bg-gray-50 border border-gray-300 text-gray-900 text-sm rounded-lg focus:ring-indigo-500 focus:border-indigo-500 block w-full p-2.5">
                        <option value="summary" selected>Summary</option>
                        <option value="platform">Platform</option>
                        <option value="pipeline">Business</option>
                        <option value="market">Market</option>
                        <option value="financials">Financials</option>
                    </select>
                </div>
            </div>
        </nav>
    </header>

    <main class="container mx-auto px-4 sm:px-6 lg:px-8 py-8 md:py-12">
        <section id="summary" class="content-section active">
            <div class="text-center mb-12">
                <h2 class="text-3xl md:text-4xl font-bold section-title">Unlocking Value in AI-Powered Antibody Discovery</h2>
                <p class="mt-4 text-lg section-intro">
                    This interactive report analyzes AbCellera Biologics (ABCL), a technology company transforming drug discovery. The thesis hinges on its proprietary AI platform, a strategic pivot to an internal clinical pipeline, and a strong financial position, positioning it at the confluence of two high-growth markets.
                </p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-6 mb-12">
                <div class="stat-card text-center">
                    <p class="text-sm font-medium kpi-label">Market Cap</p>
                    <p class="text-3xl font-bold mt-2 kpi-value">$1.12B</p>
                    <p class="text-xs text-slate-400 mt-1">As of June 2025</p>
                </div>
                <div class="stat-card text-center">
                    <p class="text-sm font-medium kpi-label">Analyst Avg. Price Target</p>
                    <p class="text-3xl font-bold mt-2 kpi-value">$8.43</p>
                    <p class="text-xs text-slate-400 mt-1">125.36% Potential Upside</p>
                </div>
                <div class="stat-card text-center">
                    <p class="text-sm font-medium kpi-label">Total Liquidity</p>
                    <p class="text-3xl font-bold mt-2 kpi-value">$810M</p>
                    <p class="text-xs text-slate-400 mt-1">Q1 2025</p>
                </div>
                <div class="stat-card text-center">
                    <p class="text-sm font-medium kpi-label">Internal Pipeline Start</p>
                    <p class="text-3xl font-bold mt-2 kpi-value">Q3 2025</p>
                    <p class="text-xs text-slate-400 mt-1">Phase 1 trials for ABCL575 & ABCL635</p>
                </div>
            </div>

            <div class="bg-white rounded-xl shadow p-6 md:p-8">
                <h3 class="text-2xl font-bold text-center section-title mb-2">Investment Core Thesis</h3>
                <p class="text-center text-slate-600 mb-8 max-w-3xl mx-auto">AbCellera's value is anchored in three key pillars: a differentiated technology platform, a strategic evolution into a clinical-stage company, and a robust financial foundation.</p>
                <div class="grid grid-cols-1 md:grid-cols-3 gap-8">
                    <div class="text-center">
                        <div class="flex items-center justify-center h-16 w-16 rounded-full bg-indigo-100 mx-auto mb-4">
                            <span class="text-3xl">üî¨</span>
                        </div>
                        <h4 class="text-lg font-semibold text-slate-800">Differentiated AI Platform</h4>
                        <p class="mt-2 text-sm text-slate-500">Full-stack, AI-powered discovery engine reduces development time by 70% with a 99.7% success rate in identifying viable candidates, creating a strong technological moat.</p>
                    </div>
                    <div class="text-center">
                        <div class="flex items-center justify-center h-16 w-16 rounded-full bg-indigo-100 mx-auto mb-4">
                           <span class="text-3xl">üíä</span>
                        </div>
                        <h4 class="text-lg font-semibold text-slate-800">High-Potential Internal Pipeline</h4>
                        <p class="mt-2 text-sm text-slate-500">Strategic pivot to develop its own drugs (ABCL575, ABCL635) targets multi-billion dollar markets. The CEO plans to accelerate this strategy, aiming for two new drug discovery pipelines annually for the next five years, totaling ten new drugs, in addition to existing partnerships.</p>
                    </div>
                    <div class="text-center">
                        <div class="flex items-center justify-center h-16 w-16 rounded-full bg-indigo-100 mx-auto mb-4">
                            <span class="text-3xl">üè¶</span>
                        </div>
                        <h4 class="text-lg font-semibold text-slate-800">Fortress Balance Sheet</h4>
                        <p class="mt-2 text-sm text-slate-500">With ~$810M in liquidity, AbCellera has a cash runway into 2026, enabling execution of clinical plans without immediate need for dilutive financing, a key competitive edge. CEO Carl Hansen, who owns about 20% of the company and has made recent purchases, underscores strong insider alignment.</p>
                    </div>
                </div>
            </div>
        </section>

        <section id="platform" class="content-section">
            <div class="text-center mb-12">
                <h2 class="text-3xl md:text-4xl font-bold section-title">The LightSpeed‚Ñ¢ AI Discovery Platform</h2>
                <p class="mt-4 text-lg section-intro">
                    AbCellera's competitive advantage is its full-stack, AI-powered platform. This section explores the core capabilities that allow it to outpace traditional methods and tackle the toughest discovery challenges.
                </p>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-8 mb-16">
                <div class="stat-card p-6">
                    <h4 class="font-bold text-lg text-slate-800">‚ö° Speed & Efficiency</h4>
                    <p class="mt-2 text-sm text-slate-600">A <strong>70% reduction</strong> in antibody development time versus traditional methods, enabling rapid response as proven with the COVID-19 therapeutic development.</p>
                </div>
                <div class="stat-card p-6">
                    <h4 class="font-bold text-lg text-slate-800">üéØ Quality & Success Rate</h4>
                    <p class="mt-2 text-sm text-slate-600">An impressive <strong>99.7% success rate</strong> in identifying viable candidates, which significantly de-risks the early stages of drug development and reduces costly late-stage failures.</p>
                </div>
                 <div class="stat-card p-6">
                    <h4 class="font-bold text-lg text-slate-800">üß¨ Diversity & Target Reach</h4>
                    <p class="mt-2 text-sm text-slate-600">Ability to screen millions of cells to find ultra-rare antibodies and tackle difficult targets like multi-pass membrane proteins that are intractable for other methods.</p>
                </div>
            </div>
            
            <div>
                 <h3 class="text-2xl font-bold text-center section-title mb-12">Key Milestones: A Journey of Innovation</h3>
                 <div class="relative timeline">
                    <div id="timeline-container"></div>
                 </div>
            </div>
        </section>

        <section id="pipeline" class="content-section">
            <div class="text-center mb-12">
                <h2 class="text-3xl md:text-4xl font-bold section-title">Business Model & Clinical Pipeline</h2>
                <p class="mt-4 text-lg section-intro">
                    AbCellera's strategy combines a robust partnership ecosystem with a high-stakes pivot to internal drug development. This dual approach diversifies revenue streams and aims to capture greater long-term value.
                </p>
            </div>
            
            <div class="grid grid-cols-1 lg:grid-cols-2 gap-12">
                <div class="bg-white rounded-xl shadow p-6 md:p-8">
                    <h3 class="text-2xl font-bold section-title mb-4">Partnership Ecosystem Growth</h3>
                    <p class="text-sm text-slate-500 mb-6">Sustained demand for AbCellera's platform is validated by consistent growth in partner-initiated programs and the number of molecules advancing to the clinic. This demonstrates strong market traction and a diverse, de-risked portfolio of future milestone and royalty opportunities.</p>
                    <div class="chart-container h-[300px] md:h-[350px]">
                        <canvas id="partnershipGrowthChart"></canvas>
                    </div>
                </div>

                <div class="bg-white rounded-xl shadow p-6 md:p-8">
                    <h3 class="text-2xl font-bold section-title mb-4">Internal Pipeline: Lead Candidates</h3>
                    <p class="text-sm text-slate-500 mb-6">The strategic pivot to an internal pipeline is spearheaded by two lead candidates targeting large, unmet medical needs, with Phase 1 trials starting Q3 2025. Success here could be a major value catalyst.</p>
                    <div class="space-y-6">
                        <div class="border border-slate-200 rounded-lg p-4">
                            <h4 class="font-bold text-indigo-700">ABCL575 - Atopic Dermatitis</h4>
                            <p class="mt-2 text-sm text-slate-600">An antibody targeting OX40L, an upstream driver of inflammation. Aims for broader inhibition and less frequent dosing than current therapies, with potential in other autoimmune conditions.</p>
                        </div>
                        <div class="border border-slate-200 rounded-lg p-4">
                            <h4 class="font-bold text-teal-700">ABCL635 - Menopause Symptoms</h4>
                            <p class="mt-2 text-sm text-slate-600">A potential first-in-class, non-hormonal antibody targeting the NK3R receptor to treat hot flashes. Addresses a $2B+ market with a potentially improved safety profile.</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="market" class="content-section">
             <div class="text-center mb-12">
                <h2 class="text-3xl md:text-4xl font-bold section-title">Dual High-Growth Market Opportunity</h2>
                <p class="mt-4 text-lg section-intro">
                    AbCellera is uniquely positioned at the intersection of two complementary and rapidly expanding markets. The growth in demand for antibody drugs directly fuels the need for the efficient, AI-powered discovery platforms that AbCellera provides.
                </p>
            </div>

            <div class="grid grid-cols-1 lg:grid-cols-2 gap-12">
                 <div class="bg-white rounded-xl shadow p-6 md:p-8">
                    <h3 class="text-xl font-bold section-title mb-2">Global Monoclonal Antibody Market</h3>
                    <p class="text-sm text-slate-500 mb-4">Driven by rising chronic disease and demand for targeted therapies, this market provides the foundational demand for AbCellera's core output.</p>
                     <div class="chart-container">
                        <canvas id="antibodyMarketChart"></canvas>
                    </div>
                </div>
                 <div class="bg-white rounded-xl shadow p-6 md:p-8">
                    <h3 class="text-xl font-bold section-title mb-2">AI-Driven Drug Discovery Market</h3>
                     <p class="text-sm text-slate-500 mb-4">Driven by the economic imperative to reduce R&D costs and timelines, this explosive market represents the demand for AbCellera's technological edge.</p>
                     <div class="chart-container">
                        <canvas id="aiMarketChart"></canvas>
                    </div>
                </div>
            </div>
        </section>

        <section id="financials" class="content-section">
             <div class="text-center mb-12">
                <h2 class="text-3xl md:text-4xl font-bold section-title">Financials, Outlook & Risks</h2>
                <p class="mt-4 text-lg section-intro">
                    This section provides an overview of AbCellera's financial performance, analyst sentiment, and the key risks. The company is in a strategic investment phase, balancing near-term losses against long-term growth potential.
                </p>
            </div>

             <div class="grid grid-cols-1 lg:grid-cols-5 gap-8 mb-12">
                <div class="lg:col-span-3 bg-white rounded-xl shadow p-6 md:p-8">
                     <h3 class="text-xl font-bold section-title mb-2">Revenue vs. Net Income (Annual)</h3>
                     <p class="text-sm text-slate-500 mb-4">Financials show the impact of declining COVID-related royalties and increasing R&D spend for the internal pipeline. This is a transitional period from short-term profits to long-term investment.</p>
                     <div class="chart-container">
                        <canvas id="financialsChart"></canvas>
                    </div>
                </div>
                <div class="lg:col-span-2 bg-white rounded-xl shadow p-6 md:p-8 flex flex-col">
                    <h3 class="text-xl font-bold section-title mb-2">Analyst Consensus</h3>
                    <p class="text-sm text-slate-500 mb-4">Wall Street sentiment remains strongly positive, reflecting confidence in the long-term strategy despite near-term unprofitability.</p>
                    <div class="chart-container flex-grow">
                        <canvas id="analystRatingChart"></canvas>
                    </div>
                </div>
            </div>

            <div>
                <h3 class="text-2xl font-bold text-center section-title mb-8">Key Risks & Challenges</h3>
                <div id="risks-accordion" class="max-w-4xl mx-auto space-y-2">
                    <!-- Accordion items will be injected by JS -->
                </div>
            </div>
        </section>
    </main>

    <footer class="bg-slate-800 text-slate-400 mt-16">
        <div class="container mx-auto px-4 sm:px-6 lg:px-8 py-4 text-center text-xs">
            <p>&copy; 2025 Investment Research Hub. All rights reserved. | 
            <a href="index.html" class="text-slate-300 hover:text-white">Back to Research Hub</a></p>
        </div>
    </footer>


    <script>
        document.addEventListener('DOMContentLoaded', function () {
            
            const APP_DATA = {
                timeline: [
                    { year: '2012', title: 'Company Founded', description: 'Established to discover antibodies from natural immune systems.' },
                    { year: '2014', title: 'First Major Pharma Partnership (Pfizer)', description: 'Validated the technology platform and business model, attracting further collaborations.' },
                    { year: '2018', title: 'Awarded DARPA P3 Program Contract', description: 'Received $30M in non-dilutive funding to develop rapid pandemic response capabilities.' },
                    { year: '2020', title: 'Co-developed Bamlanivimab with Eli Lilly', description: 'Demonstrated platform speed by delivering a COVID-19 therapeutic in record time.' },
                    { year: '2020', title: 'Initial Public Offering (IPO) on Nasdaq', description: 'Raised ~$555.5M, providing significant capital for expansion and R&D.' },
                    { year: '2022', title: 'Opened GMP Manufacturing Facility', description: 'Expanded capabilities into clinical manufacturing for a more integrated development process.' },
                    { year: '2024', title: 'Continued Pipeline Diversification', description: 'Strategic focus on expanding internal and partnered programs beyond COVID-19.' },
                ],
                partnershipGrowth: {
                    labels: ['Dec 2022', 'Jun 2023', 'Dec 2023', 'Jun 2024', 'Mar 2025'],
                    programs: [75, 80, 87, 93, 97],
                    molecules: [8, 9, 13, 14, 16],
                },
                marketAntibody: {
                    labels: ['2024', '2025', '2026', '2027', '2028', '2029', '2030', '2031'],
                    data: [249.14, 283.77, 323.21, 368.14, 419.31, 477.59, 543.95, 619.60],
                },
                marketAI: {
                    labels: ['2024', '2026', '2028', '2030', '2032', '2034'],
                    data: [1.85, 3.09, 5.16, 8.62, 14.39, 18.65],
                },
                financials: {
                    labels: ['2022', '2023', '2024(E)', '2025(E)'],
                    revenue: [485.4, 38.0, 28.8, 27.6],
                    netIncome: [158.5, -146.4, -162.9, -167.9],
                },
                analystRatings: {
                    labels: ['Strong Buy', 'Hold'],
                    data: [8, 1],
                },
                risks: [
                    { title: 'Uncertainty in Drug Development', content: 'Biological molecule development is inherently uncertain. There is no guarantee of regulatory approval or commercial success, and timelines are unpredictable.' },
                    { title: 'Market Competition', content: 'AbCellera faces significant competition from established drugs and other biotech firms in the key markets it is entering with its internal pipeline.' },
                    { title: 'Revenue Volatility', content: 'The company has experienced sharp declines in revenue post-COVID. The shift to internal programs consumes more resources and impacts short-term financial stability.' },
                    { title: 'Financial Hurdles', content: 'The company faces widening net losses and negative free cash flow due to heavy R&D investment. Sustained losses may eventually require raising additional capital.' },
                    { title: 'Technological Disruption', content: 'The biotech landscape is characterized by rapid change. Continued success depends on maintaining a technological edge over new and emerging platforms.' }
                ]
            };

            function init() {
                renderTimeline();
                renderRisksAccordion();
                createPartnershipGrowthChart();
                createMarketCharts();
                createFinancialsChart();
                createAnalystRatingChart();
            }

            function renderTimeline() {
                const container = document.getElementById('timeline-container');
                let content = '';
                APP_DATA.timeline.forEach((item, index) => {
                    const sideClass = index % 2 === 0 ? 'md:pr-8 text-right' : 'md:pl-8 text-left';
                    const itemClass = index % 2 === 0 ? 'md:flex-row' : 'md:flex-row-reverse';
                    content += `
                        <div class="timeline-item flex justify-between items-center w-full mb-8 ${itemClass}">
                            <div class="order-1 w-5/12"></div>
                            <div class="z-20 flex items-center order-1 bg-indigo-600 shadow-xl w-8 h-8 rounded-full">
                                <h1 class="mx-auto font-semibold text-sm text-white">${item.year}</h1>
                            </div>
                            <div class="order-1 bg-white rounded-lg shadow-xl w-5/12 px-6 py-4 timeline-content">
                                <h3 class="font-bold text-slate-800 text-md">${item.title}</h3>
                                <p class="text-sm leading-snug tracking-wide text-slate-500 text-opacity-100">${item.description}</p>
                            </div>
                        </div>
                    `;
                });
                container.innerHTML = content;
            }

            function renderRisksAccordion() {
                const container = document.getElementById('risks-accordion');
                let content = '';
                APP_DATA.risks.forEach((risk, index) => {
                    content += `
                        <div class="accordion-item bg-white border border-slate-200 rounded-lg">
                            <h2>
                                <button type="button" class="flex items-center justify-between w-full p-5 font-medium text-left text-slate-700 hover:bg-slate-100" data-accordion-target="#accordion-body-${index}">
                                    <span>${risk.title}</span>
                                    <svg class="w-3 h-3 rotate-180 shrink-0" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 10 6">
                                        <path stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 5 5 1 1 5"/>
                                    </svg>
                                </button>
                            </h2>
                            <div id="accordion-body-${index}" class="accordion-content">
                                <div class="p-5 border-t border-slate-200">
                                    <p class="mb-2 text-slate-500">${risk.content}</p>
                                </div>
                            </div>
                        </div>
                    `;
                });
                container.innerHTML = content;
                
                container.querySelectorAll('button').forEach(button => {
                    button.addEventListener('click', () => {
                        const content = button.parentElement.nextElementSibling;
                        const icon = button.querySelector('svg');
                        const isExpanded = content.style.maxHeight && content.style.maxHeight !== '0px';
                        
                        content.style.maxHeight = isExpanded ? '0px' : content.scrollHeight + 'px';
                        icon.style.transform = isExpanded ? 'rotate(180deg)' : 'rotate(0deg)';
                    });
                });
            }
            
            const chartDefaultOptions = {
                responsive: true,
                maintainAspectRatio: false,
                plugins: {
                    legend: {
                        position: 'bottom',
                        labels: {
                            font: {
                                family: "'Poppins', sans-serif"
                            },
                            boxWidth: 12,
                            padding: 20
                        }
                    },
                    tooltip: {
                        enabled: true,
                        backgroundColor: '#1e293b',
                        titleFont: {
                            family: "'Poppins', sans-serif",
                            weight: 'bold'
                        },
                        bodyFont: {
                            family: "'Poppins', sans-serif"
                        },
                        padding: 10,
                        cornerRadius: 4,
                    }
                },
                scales: {
                    y: {
                        border: { display: false },
                        grid: { color: '#e2e8f0' },
                        ticks: {
                            font: { family: "'Poppins', sans-serif" }
                        }
                    },
                    x: {
                        grid: { display: false },
                        ticks: {
                            font: { family: "'Poppins', sans-serif" }
                        }
                    }
                }
            };
            
            function createPartnershipGrowthChart() {
                const ctx = document.getElementById('partnershipGrowthChart').getContext('2d');
                new Chart(ctx, {
                    type: 'bar',
                    data: {
                        labels: APP_DATA.partnershipGrowth.labels,
                        datasets: [
                            {
                                label: 'Partner-initiated Program Starts',
                                data: APP_DATA.partnershipGrowth.programs,
                                backgroundColor: '#4f46e5',
                                borderColor: '#4338ca',
                                borderWidth: 1
                            },
                            {
                                label: 'Molecules in Clinic',
                                data: APP_DATA.partnershipGrowth.molecules,
                                backgroundColor: '#14b8a6',
                                borderColor: '#0f766e',
                                borderWidth: 1
                            }
                        ]
                    },
                    options: chartDefaultOptions
                });
            }

            function createMarketCharts() {
                const antibodyCtx = document.getElementById('antibodyMarketChart').getContext('2d');
                new Chart(antibodyCtx, {
                    type: 'line',
                    data: {
                        labels: APP_DATA.marketAntibody.labels,
                        datasets: [{
                            label: 'Market Size ($B)',
                            data: APP_DATA.marketAntibody.data,
                            fill: true,
                            borderColor: '#4f46e5',
                            backgroundColor: 'rgba(79, 70, 229, 0.1)',
                            tension: 0.3
                        }]
                    },
                    options: { ...chartDefaultOptions, plugins: { ...chartDefaultOptions.plugins, legend: {display: false} } }
                });

                const aiCtx = document.getElementById('aiMarketChart').getContext('2d');
                new Chart(aiCtx, {
                    type: 'line',
                    data: {
                        labels: APP_DATA.marketAI.labels,
                        datasets: [{
                            label: 'Market Size ($B)',
                            data: APP_DATA.marketAI.data,
                            fill: true,
                            borderColor: '#14b8a6',
                            backgroundColor: 'rgba(20, 184, 166, 0.1)',
                            tension: 0.3
                        }]
                    },
                    options: { ...chartDefaultOptions, plugins: { ...chartDefaultOptions.plugins, legend: {display: false} } }
                });
            }

            function createFinancialsChart() {
                const ctx = document.getElementById('financialsChart').getContext('2d');
                new Chart(ctx, {
                    type: 'bar',
                    data: {
                        labels: APP_DATA.financials.labels,
                        datasets: [
                             {
                                label: 'Total Revenue ($M)',
                                data: APP_DATA.financials.revenue,
                                backgroundColor: '#a5b4fc',
                                yAxisID: 'y',
                                order: 2
                            },
                            {
                                label: 'Net Income ($M)',
                                data: APP_DATA.financials.netIncome,
                                backgroundColor: '#f87171',
                                borderColor: '#ef4444',
                                type: 'line',
                                yAxisID: 'y',
                                tension: 0.1,
                                order: 1
                            }
                        ]
                    },
                    options: {
                        ...chartDefaultOptions,
                        scales: {
                           ...chartDefaultOptions.scales,
                           y: {
                                type: 'linear',
                                display: true,
                                position: 'left',
                                title: { display: true, text: 'USD ($M)'}
                           }
                        }
                    }
                });
            }

            function createAnalystRatingChart() {
                const ctx = document.getElementById('analystRatingChart').getContext('2d');
                new Chart(ctx, {
                    type: 'doughnut',
                    data: {
                        labels: APP_DATA.analystRatings.labels,
                        datasets: [{
                            label: '# of Analysts',
                            data: APP_DATA.analystRatings.data,
                            backgroundColor: ['#4f46e5', '#f59e0b'],
                            borderColor: '#ffffff',
                            borderWidth: 2
                        }]
                    },
                    options: {
                        responsive: true,
                        maintainAspectRatio: false,
                        plugins: {
                            legend: {
                                position: 'bottom',
                                labels: {
                                    font: { family: "'Poppins', sans-serif" },
                                    boxWidth: 12,
                                    padding: 20
                                }
                            },
                            tooltip: chartDefaultOptions.plugins.tooltip
                        },
                        cutout: '60%'
                    }
                });
            }

            init();
        });

        function showSection(sectionId) {
            const sections = document.querySelectorAll('.content-section');
            sections.forEach(section => {
                section.classList.remove('active');
            });
            document.getElementById(sectionId).classList.add('active');

            const navLinks = document.querySelectorAll('.nav-link');
            navLinks.forEach(link => {
                link.classList.remove('active');
                if (link.getAttribute('onclick').includes(sectionId)) {
                    link.classList.add('active');
                }
            });
        }
    </script>
</body>
</html>
